
Craig D. Ricci
Examiner (ID: 6907, Phone: (571)270-5864 , Office: P/1628 )
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1611, 1628, 1614 |
| Total Applications | 1601 |
| Issued Applications | 776 |
| Pending Applications | 153 |
| Abandoned Applications | 697 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19769930
[patent_doc_number] => 20250051356
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-13
[patent_title] => RIFABUTIN ANALOGS FOR THE TREATMENT OF DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/722156
[patent_app_country] => US
[patent_app_date] => 2022-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39081
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18722156
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/722156 | RIFABUTIN ANALOGS FOR THE TREATMENT OF DISEASE | Dec 20, 2022 | Pending |
Array
(
[id] => 20024821
[patent_doc_number] => 20250163043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-22
[patent_title] => CDK9 INHIBITOR AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/719765
[patent_app_country] => US
[patent_app_date] => 2022-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 66278
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18719765
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/719765 | CDK9 INHIBITOR AND USE THEREOF | Dec 15, 2022 | Pending |
Array
(
[id] => 19767610
[patent_doc_number] => 20250049036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-13
[patent_title] => SUBSTITUTED FUSED BICYCLIC PYRIDINE CARBOXAMIDE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI
[patent_app_type] => utility
[patent_app_number] => 18/720255
[patent_app_country] => US
[patent_app_date] => 2022-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50751
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 1058
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18720255
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/720255 | SUBSTITUTED FUSED BICYCLIC PYRIDINE CARBOXAMIDE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI | Dec 15, 2022 | Pending |
Array
(
[id] => 20320082
[patent_doc_number] => 20250332170
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-10-30
[patent_title] => VANDETANIB REDUCES INFLAMMATORY CYTOKINES AND AMELIORATES COVID-19
[patent_app_type] => utility
[patent_app_number] => 18/720768
[patent_app_country] => US
[patent_app_date] => 2022-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10923
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18720768
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/720768 | VANDETANIB REDUCES INFLAMMATORY CYTOKINES AND AMELIORATES COVID-19 | Dec 14, 2022 | Pending |
Array
(
[id] => 18334709
[patent_doc_number] => 20230126657
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => Compositions and Methods for Identifying and Treating Dystonia Disorders
[patent_app_type] => utility
[patent_app_number] => 18/082570
[patent_app_country] => US
[patent_app_date] => 2022-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22487
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18082570
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/082570 | Compositions and Methods for Identifying and Treating Dystonia Disorders | Dec 14, 2022 | Abandoned |
Array
(
[id] => 19767609
[patent_doc_number] => 20250049035
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-13
[patent_title] => MICROBIOCIDAL BICYCLE HETEROCYCLIC DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 18/720036
[patent_app_country] => US
[patent_app_date] => 2022-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34546
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 398
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18720036
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/720036 | MICROBIOCIDAL BICYCLE HETEROCYCLIC DERIVATIVES | Dec 12, 2022 | Pending |
Array
(
[id] => 19769866
[patent_doc_number] => 20250051292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-13
[patent_title] => PROCESS FOR MANUFACTURING A MIXTURE COMPRISING A DIMERIC MACROCYCLE INTERMEDIATE OF A GADOLINIUM COMPLEX
[patent_app_type] => utility
[patent_app_number] => 18/718945
[patent_app_country] => US
[patent_app_date] => 2022-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8284
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18718945
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/718945 | PROCESS FOR MANUFACTURING A MIXTURE COMPRISING A DIMERIC MACROCYCLE INTERMEDIATE OF A GADOLINIUM COMPLEX | Dec 12, 2022 | Pending |
Array
(
[id] => 19832308
[patent_doc_number] => 20250084094
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-13
[patent_title] => SPIROCYCLIC INHIBITORS OF APOL1 AND METHODS OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 18/714031
[patent_app_country] => US
[patent_app_date] => 2022-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39391
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -46
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18714031
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/714031 | SPIROCYCLIC INHIBITORS OF APOL1 AND METHODS OF USING SAME | Nov 28, 2022 | Pending |
Array
(
[id] => 19844365
[patent_doc_number] => 20250089716
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-20
[patent_title] => IMMEDIATE-RELEASE PESTICIDE FORMULATION
[patent_app_type] => utility
[patent_app_number] => 18/730944
[patent_app_country] => US
[patent_app_date] => 2022-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9741
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18730944
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/730944 | IMMEDIATE-RELEASE PESTICIDE FORMULATION | Nov 27, 2022 | Pending |
Array
(
[id] => 18725758
[patent_doc_number] => 20230339967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => SOLID FORMS OF AN S1P-RECEPTOR MODULATOR
[patent_app_type] => utility
[patent_app_number] => 17/992457
[patent_app_country] => US
[patent_app_date] => 2022-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19818
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17992457
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/992457 | SOLID FORMS OF AN S1P-RECEPTOR MODULATOR | Nov 21, 2022 | Abandoned |
Array
(
[id] => 20779427
[patent_doc_number] => 20260167620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-06-18
[patent_title] => MULTIFUNCTIONAL COMPOUND CAPABLE OF DEGRADING BTK KINASE, AND COMPOSITION AND USE
[patent_app_type] => utility
[patent_app_number] => 18/710596
[patent_app_country] => US
[patent_app_date] => 2022-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12898
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 414
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18710596
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/710596 | MULTIFUNCTIONAL COMPOUND CAPABLE OF DEGRADING BTK KINASE, AND COMPOSITION AND USE | Nov 21, 2022 | Pending |
Array
(
[id] => 19722791
[patent_doc_number] => 20250025542
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-23
[patent_title] => COMPOSITIONS AND METHODS FOR INDUCING IMMUNE TOLERANCE
[patent_app_type] => utility
[patent_app_number] => 18/708916
[patent_app_country] => US
[patent_app_date] => 2022-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27553
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -195
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18708916
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/708916 | COMPOSITIONS AND METHODS FOR INDUCING IMMUNE TOLERANCE | Nov 8, 2022 | Pending |
Array
(
[id] => 20328446
[patent_doc_number] => 12458703
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-04
[patent_title] => Responsive elastic polymers and methods of making and using same
[patent_app_type] => utility
[patent_app_number] => 17/982454
[patent_app_country] => US
[patent_app_date] => 2022-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 26
[patent_no_of_words] => 2702
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 171
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17982454
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/982454 | Responsive elastic polymers and methods of making and using same | Nov 6, 2022 | Issued |
Array
(
[id] => 19667447
[patent_doc_number] => 12180174
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-31
[patent_title] => A2-73 crystalline polymorph compositions of matter and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 17/978818
[patent_app_country] => US
[patent_app_date] => 2022-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 44
[patent_no_of_words] => 23692
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17978818
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/978818 | A2-73 crystalline polymorph compositions of matter and methods of use thereof | Oct 31, 2022 | Issued |
Array
(
[id] => 19642849
[patent_doc_number] => 20240417369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-19
[patent_title] => RXFP1 AGONISTS
[patent_app_type] => utility
[patent_app_number] => 18/700868
[patent_app_country] => US
[patent_app_date] => 2022-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15652
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 658
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18700868
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/700868 | RXFP1 AGONISTS | Oct 27, 2022 | Pending |
Array
(
[id] => 18496015
[patent_doc_number] => 20230218542
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => MEDICAMENT FOR TREATING HYPERTENSION
[patent_app_type] => utility
[patent_app_number] => 17/970577
[patent_app_country] => US
[patent_app_date] => 2022-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4299
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17970577
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/970577 | MEDICAMENT FOR TREATING HYPERTENSION | Oct 20, 2022 | Abandoned |
Array
(
[id] => 20098915
[patent_doc_number] => 20250228851
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-17
[patent_title] => ALLOSTERIC INHIBITOR COMPOUNDS FOR OVERCOMING CANCER RESISTANCE
[patent_app_type] => utility
[patent_app_number] => 18/703228
[patent_app_country] => US
[patent_app_date] => 2022-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17145
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18703228
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/703228 | ALLOSTERIC INHIBITOR COMPOUNDS FOR OVERCOMING CANCER RESISTANCE | Oct 19, 2022 | Pending |
Array
(
[id] => 18176952
[patent_doc_number] => 20230037681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => FOOD INGREDIENTS FROM STEVIA REBAUDIANA
[patent_app_type] => utility
[patent_app_number] => 17/969235
[patent_app_country] => US
[patent_app_date] => 2022-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2307
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17969235
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/969235 | FOOD INGREDIENTS FROM STEVIA REBAUDIANA | Oct 18, 2022 | Abandoned |
Array
(
[id] => 19692774
[patent_doc_number] => 20250011319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-09
[patent_title] => SUBSTITUTED 1H-PYRAZOLO [4,3-c] QUINOLINES, METHODS OF PREPARATION, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/701223
[patent_app_country] => US
[patent_app_date] => 2022-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22025
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18701223
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/701223 | SUBSTITUTED 1H-PYRAZOLO [4,3-c] QUINOLINES, METHODS OF PREPARATION, AND USE THEREOF | Oct 2, 2022 | Pending |
Array
(
[id] => 19629653
[patent_doc_number] => 20240408102
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-12
[patent_title] => RESMETIROM FOR REDUCING LIVER VOLUME
[patent_app_type] => utility
[patent_app_number] => 18/695572
[patent_app_country] => US
[patent_app_date] => 2022-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10432
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18695572
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/695572 | RESMETIROM FOR REDUCING LIVER VOLUME | Sep 26, 2022 | Pending |